ABRA Antikörper (C-Term)
Kurzübersicht für ABRA Antikörper (C-Term) (ABIN950219)
Target
Alle ABRA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 282-312, C-Term
-
Spezifität
- This antibody reacts to ABRA / STARS.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 282-312 amino acids from the C-terminal region of human ABRA
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ABRA (Actin-Binding rho Activating Protein (ABRA))
-
Andere Bezeichnung
- ABRA / STARS
-
Hintergrund
- ABRA acts as an activator of serum response factor (SRF)-dependent transcription possibly by inducing nuclear translocation of MKL1 or MKL2 and through a mechanism requiring Rho-actin signaling (By similarity).Synonyms: Actin-binding Rho-activating protein, Striated muscle activator of Rho-dependent signaling
-
Gen-ID
- 137735
-
NCBI Accession
- NP_631905
-
Pathways
- Protein targeting to Nucleus
Target
-